WILLIAM S REARDON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM S REARDON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM S REARDON. WILLIAM S REARDON is Director in TEKLA HEALTHCARE INVESTORS ($HQH) and Director in TEKLA LIFE SCIENCES INVESTORS ($HQL) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in SYNTA PHARMACEUTICALS CORP ($SNTA) and Director in Tekla Healthcare Opportunities Fund ($THQ) and Director in Tekla World Healthcare Fund ($THW).
Latest Insider Trading Transactions of WILLIAM S REARDON
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDRA, SNTA, HQH, THQ, HQL, THW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2021 | THW | Tekla World Health ... | REARDON WILLIAM S | Director | Option Exercise | X | 14.26 | 1,460 | 20,823 | 0 | |
Apr 08 2021 | THW | Tekla World Health ... | REARDON WILLIAM S | Director | Buy | X | 14.26 | 486 | 6,931 | 1,946 | 1.5 K to 1.9 K (+33.29 %) |
Mar 01 2021 | THQ | Tekla Healthcare O ... | REARDON WILLIAM S | Director | Buy | P | 20.85 | 1,196 | 24,937 | 1,196 | 0 to 1.2 K |
Mar 01 2021 | THW | Tekla World Health ... | REARDON WILLIAM S | Director | Buy | P | 17.14 | 1,460 | 25,024 | 1,460 | 0 to 1.5 K |
Jun 22 2018 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.53 | 50,000 | 76,500 | 50,000 | |
Jul 07 2017 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 1.75 | 7,714 | 13,500 | 32,973 | 25.3 K to 33 K (+30.54 %) |
Jun 09 2017 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.63 | 50,000 | 81,500 | 50,000 | |
Jul 06 2016 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 1.63 | 4,102 | 6,686 | 25,259 | 21.2 K to 25.3 K (+19.39 %) |
Jun 15 2016 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.44 | 35,000 | 50,400 | 35,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 2,272 | 0 | 49,392 | 47.1 K to 49.4 K (+4.82 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 5,681 | 0 | 47,120 | 41.4 K to 47.1 K (+13.71 %) |
Jun 10 2015 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 3.59 | 35,000 | 125,650 | 35,000 | |
Jul 03 2014 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 2.83 | 2,363 | 6,687 | 21,157 | 18.8 K to 21.2 K (+12.57 %) |
Jun 11 2014 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 3.25 | 35,000 | 113,750 | 35,000 | |
Sep 17 2013 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 1.82 | 13,561 | 24,643 | 18,794 | 5.2 K to 18.8 K (+259.14 %) |
Aug 16 2013 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.50 | 40,000 | 60,000 | 40,000 | |
Jul 30 2013 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 | |
Jun 13 2012 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.91 | 20,000 | 18,200 | 20,000 | |
Mar 12 2012 | HQL | TEKLA LIFE SCIENCE ... | REARDON WILLIAM S | Director | Buy | P | 13.27 | 772 | 10,241 | 772 | 0 to 772 |
Mar 12 2012 | HQH | TEKLA HEALTHCARE I ... | REARDON WILLIAM S | Director | Buy | P | 15.86 | 646 | 10,242 | 646 | 0 to 646 |
Jun 16 2011 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 2.18 | 20,000 | 43,600 | 20,000 | |
Jun 15 2010 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 4.16 | 10,000 | 41,600 | 10,000 | |
Jun 16 2009 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 6.72 | 10,000 | 67,200 | 10,000 | |
Apr 03 2009 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 6.25 | 1,070 | 6,688 | 5,233 | 4.2 K to 5.2 K (+25.70 %) |
Jun 05 2008 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 14.21 | 10,000 | 142,100 | 10,000 | |
Jan 29 2008 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 13.28 | 16,000 | 212,480 | 16,000 | |
Jan 08 2008 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 13.10 | 1,250 | 16,375 | 1,250 | |
Jan 04 2008 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 11.29 | 155 | 1,750 | 4,163 | 4 K to 4.2 K (+3.87 %) |
Oct 03 2007 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 8.95 | 1,250 | 11,188 | 1,250 | |
Oct 03 2007 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 7.61 | 230 | 1,750 | 4,008 | 3.8 K to 4 K (+6.09 %) |
Jul 05 2007 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 5.58 | 448 | 2,502 | 3,778 | 3.3 K to 3.8 K (+13.45 %) |
Jun 28 2007 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.00 | 1,250 | 0 | 1,250 | |
Apr 05 2007 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 7.65 | 458 | 3,504 | 3,330 | 2.9 K to 3.3 K (+15.95 %) |
Apr 03 2007 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 8.59 | 1,250 | 10,738 | 1,250 | |
Jan 03 2007 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 5.39 | 1,250 | 6,738 | 1,250 | |
Oct 02 2006 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 4.10 | 1,250 | 5,125 | 1,250 | |
Jul 07 2006 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 3.36 | 745 | 2,501 | 2,872 | 2.1 K to 2.9 K (+35.03 %) |
Jul 06 2006 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 4.06 | 1,250 | 5,075 | 1,250 | |
Apr 04 2006 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.63 | 10,000 | 6,300 | 10,000 | |
Jan 03 2006 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.61 | 10,000 | 6,100 | 10,000 | |
Oct 04 2005 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.67 | 10,000 | 6,700 | 10,000 | |
Jul 05 2005 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.56 | 10,000 | 5,600 | 10,000 | |
Apr 04 2005 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.60 | 10,000 | 6,000 | 10,000 | |
Apr 04 2005 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 0.51 | 5,882 | 3,000 | 17,016 | 11.1 K to 17 K (+52.83 %) |
Jan 03 2005 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.48 | 3,750 | 1,800 | 3,750 | |
Oct 04 2004 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.63 | 3,750 | 2,363 | 3,750 | |
Jul 12 2004 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 0.54 | 5,974 | 3,250 | 11,134 | 5.2 K to 11.1 K (+115.78 %) |
Jul 02 2004 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 0.64 | 3,750 | 2,400 | 3,750 | |
Apr 02 2004 | IDRA | IDERA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 1.04 | 3,750 | 3,900 | 3,750 |
Page: 1